Takeda Sues Generic Makers Over Diabetes Drug Patents
Japan's largest pharmaceutical company, Takeda Chemical Industries, and its U.S. subsidiary filed lawsuits against three generic drug makers for patent infringement in the U.S. District Court for the Southern District of...To view the full article, register now.
Already a subscriber? Click here to view full article